Navigation Links
Unigene's Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
Date:12/12/2012

oint; the ability to treat osteoporosis with an orally delivered therapeutic; the continued advancement of Unigene's oral PTH program; and Unigene's ability to build a robust portfolio of proprietary partnerships in peptide-based therapeutics based on its Peptelligence™ platform. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors. These known and unknown risk factors include, but are not limited to: the delay in obtaining or the failure to obtain regulatory approvals for our products and the products of our licensees that may generate royalty and milestone payments to us, our ability to achieve product sales and royalties, competition, our dependence on other companies to commercialize, manufacture and sell products using our technologies and our ability to enter into favorable new agreements with such companies, our ability to cut expenses and maintain efficiencies, our ability to enter into new financing arrangements,  the ability of our products to gain market acceptance and increase market share, the uncertainty of results of animal and human testing, the risk of product liability and liability for human clinical trials, our dependence on patents and other proprietary rights and the risks associated with patent litigation, dependence on key management officials, the availability and cost of capital, the availability of qualified personnel, changes in, or the failure to comply with, governmental regulations, general economic and business conditions, our history of losses and ability to achieve profitability, litigation and other risk factors discussed in our Securities and Exchange Commission ("SEC") filings, including our annual report on Form 10-K and our quarterly reports on F
'/>"/>
SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
2. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
3. uniQure Initiates Phase I in Acute Intermittent Porphyria
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
6. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
7. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
8. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
9. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
10. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
11. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  Decision Resources ... preclinical animal research imaging system market ... multimodality imaging, such as combining computed tomography and ... imaging. This demand stems from the need for ... among scientific journals, which will spur preclinical imaging ...
(Date:7/30/2014)... WESTFORD, Mass. , July 30, 2014 ... in laser- and light-based aesthetic treatments for non-invasive and minimally ... promoted Executive Vice President, Chief Operating Officer and Chief Financial ... Company, effective August 1, 2014.  Baker, 53, will continue to ... from Michael Davin , who remains Chairman and Chief ...
(Date:7/30/2014)... PHILADELPHIA , July 30, 2014  Packaging Coordinators, ... a definitive agreement to acquire Penn Pharmaceutical Services Limited ... Wales in the United Kingdom ... New Hope, Pennsylvania and Tokyo ... manufacturing services, including Clinical and Commercial dosage form manufacturing, ...
Breaking Medicine Technology:Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
... AVENTURA, Fla., Aug. 15, 2011 Double Eagle ... has retained National Securities Corporation as the ... round of capitalization, as well as possible acquisition and ... company of Fuse Science, Inc. ( www.fusescience.com ), the ...
... MINNETONKA, Minn., Aug. 15, 2011 Uroplasty, Inc. (Nasdaq: ... develops, manufactures and markets innovative proprietary products to treat ... clinical studies using Uroplasty,s Urgent® PC Neuromodulation System are ... meeting, August 29-September 2, 2011 in Glasgow, Scotland.   ...
Cached Medicine Technology:Double Eagle Holdings Chooses National Securities Corporation as Exclusive Investment Banker 2Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society 2Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society 3
(Date:7/31/2014)... Eagle, Colorado (PRWEB) July 31, 2014 ... Challenge returns to Colorado’s Gore Range September 12-14, ... multi-sport, multi-team adventure race features teams of disabled and ... described as one of America’s most challenging by experienced ... del Rio fishing resort along the Colorado River ...
(Date:7/31/2014)... City, NY (PRWEB) July 31, 2014 ... chocolate , will be available in New York's favorite ... in August. BRC is known for their commitment to ... Associated Press. , Chocolatto® is the new sensation from ... hot chocolate ! A delicious highly popular Italian dessert ...
(Date:7/31/2014)... July 31, 2014 Nuanced Media, a ... launch of the Nuanced Medical website . Nuanced ... the needs of the Medical Industry. , The idea ... services for medical practices to meet continuously changing federal ... the HIPAA Act (Health Insurance Portability and Accountability Act), ...
(Date:7/30/2014)... Ohio (PRWEB) July 31, 2014 CareSource, ... Douglas A. Fecher President and CEO, Wright-Patt Credit Union, ... Fecher, is a foremost financial CEO with an extensive ... president of lending and later chief operating officer at ... Fecher has led the Beavercreek-based Wright-Patt Credit Union that ...
(Date:7/30/2014)... 31, 2014 Regardless of traumatic events experienced during ... develop a drinking problem if faced with civilian life ... financial and legal problems all commonplace in military ... University,s Mailman School of Public Health are published online ... , Alcohol abuse is a major concern for reservists ...
Breaking Medicine News(10 mins):Health News:World T.E.A.M. Sports’ Adventure Team Challenge Returns to Colorado’s High Country 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge Returns to Colorado’s High Country 3Health News:Dolce Vite Chocolatto® - World's Best Thick Dark Italian Hot Chocolate Now Available at NYC's Favorite Cafe Brooklyn Roasting Company 2Health News:Nuanced Media, HIPAA Certified Agency, Launches Medical Web Design Service Website 2Health News:Veterans' alcohol problems linked to stress on the home front 2
... ... 1980,s and is now a major health concern with no known cure. The causes of ... , ... -- Following remarkable improvement in the condition of children who have received this stem cell ...
... ... ... -- LML Music announces the April 13, 2010 release of , in my ... room, was conceived and produced by LML recording artist D.C. Anderson , the prolific ...
... ... and introduces new, ,Band Aid, versions of common cosmetic surgery procedures. , ... (Vocus) April 13, 2010 -- Atlanta Plastic ... Aid Lipo, – a less invasive, more cost effective mini liposuction procedure. Similar to ...
... ... suffering from keratoconus , ... April 12, 2010 -- Khanna Institute will now be offering Intacs of 400 ... Intacs corneal implants Addition Technology, Inc., that it has received FDA approval for an expanded ...
... ... the industry are faced with the daunting task to either establish or rethink their B2C ... more urgent by new government regulations, fees and taxes, and ever-present competitive factors that will ... ...
... ERs for help rather than a doctor,s office, study finds ... uninsured or who are on Medicaid are much less likely ... have private coverage. , In fact, more than 5.5 million ... their migraines because of their insurance status, a new study ...
Cached Medicine News:Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 2Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 3Health News:Thanks to a New Stem Cell Therapy, a 9-year Old Autistic Boy Talks to his Father for the First Time 4Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 2Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 3Health News:Peter Bradley Adams, Victoria Shaw, Many Distinguished Colleagues Ally To Benefit National MS Society With CD Release: In My Room 4Health News:Atlanta Plastic Surgeon Dr. John LeRoy Expands on Success of 'Band-Aid Facelift' to Offer 'Band Aid Lipo' 2Health News:Atlanta Plastic Surgeon Dr. John LeRoy Expands on Success of 'Band-Aid Facelift' to Offer 'Band Aid Lipo' 3Health News:Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus 2Health News:Khanna Institute to Offer Newly FDA Approved Expanded Range of Intacs for Keratoconus 3Health News:ConnextionsHealth Poised to Help Organizations Leverage Revenue-Driving Opportunities Related to Health Reform 2Health News:ConnextionsHealth Poised to Help Organizations Leverage Revenue-Driving Opportunities Related to Health Reform 3Health News:Finding Good Migraine Care a Headache for the Uninsured 2Health News:Finding Good Migraine Care a Headache for the Uninsured 3
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi...
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Unique molecular suspension in methanol for ... chromosome, and histology smears. Our special ... rapidly penetrates cellular elements producing unequaled ... detail and unexcelled brilliance in the ...
Wright-Giemsa Stain Solutions...
Medicine Products: